DME
Clinical trials for DME explained in plain language.
Never miss a new study
Get alerted when new DME trials appear
Sign up with your email to follow new studies for DME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye drug could reduce shots for Diabetes-Related vision loss
Disease control Recruiting nowThis study tests a new medicine called EYP-1901 against a standard treatment (aflibercept) for people with diabetic macular edema, a condition that causes vision loss in people with diabetes. About 240 participants will receive either the new drug or the standard one, and researc…
Matched conditions: DME
Phase: PHASE3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 11:01 UTC
-
New eye drug could mean fewer shots for Diabetes-Related vision loss
Disease control Recruiting nowThis study tests a new medicine called EYP-1901 against a standard treatment (aflibercept) for people with diabetic macular edema, a condition that causes blurry vision due to diabetes. About 240 adults will receive either the new drug or the standard one, and researchers will ch…
Matched conditions: DME
Phase: PHASE3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC